Back to search

Article

Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthma

2023-11-15

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Prostaglandin D2 (PGD2) signals via the DP1 and DP2 receptors. In Phase II trials, DP2 antagonism decreased airway inflammation and airway smooth muscle (ASM) area in patients with moderate-to-severe asthma, but in the Phase III clinical trials, DP2 antagonism failed to significantly lower the rate of exacerbations. Here, we hypothesised that DP2 antagonism resolves establis...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3def7d58-5ad0-50e1-8a93-838afd9578ba
DOI
10.1101/2023.11.12.566772
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Dual therapy with corticosteroid ablates the beneficial effect of DP2 antagonism in chronic experimental asthmaDOI 10.1101/2023.11.12.566772
Select a neighboring publication to make it the new centre.